Unlocking the Power of TOFA: Boosting Energy Expenditure in Obesity Models with a Novel Dietary Approach for Weight Loss and Improved Metabolic Health
New scientific findings from researchers at UC Berkeley point to a dual-action molecular compound called TOFA as a potential breakthrough for treating obesity and metabolic disorders like diabetes, offering a metabolic boost that preserves lean muscle mass unlike widely used GLP-1 medications such as Ozempic and Wegovy. How TOFA Targets Energy Expenditure Differently Than GLP-1s … Read more